Login / Signup

Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma.

Clementine Boccon-GibodAlexis TalbotFabien Le BrasLaurent FrenzelBruno RoyerStephanie HarelNaelle LombionKarim BelhadjWendy CuccuiniBertrand Arnulf
Published in: British journal of haematology (2020)
Keyphrases
  • multiple myeloma
  • high dose
  • chronic lymphocytic leukemia
  • low dose
  • diffuse large b cell lymphoma
  • acute myeloid leukemia